Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to determine the feasibility of long-acting injectable
naltrexone administration in a clinical trial in patients with SMI who also have a diagnosis
of alcohol dependence. Secondary aims include providing a preliminary assessment of the
tolerability and safety of long-acting injectable naltrexone as compared with oral naltrexone
in patients with SMI who also have a diagnosis of alcohol dependence. An additional aim is to
provide a preliminary assessment of the efficacy of long-acting injectable naltrexone as
compared with oral naltrexone in reducing alcohol use from baseline levels
Phase:
Phase 4
Details
Lead Sponsor:
State University of New York - Upstate Medical University